The emerging role of B cells in immune-mediated demyelinating diseases: mechanisms and therapeutic implications
Role of B Cells in Demyelination B cells play a pivotal role in the pathology of demyelinating diseases, such as […]
When the Disc Strikes: Rethinking Fibrocartilaginous Embolism
Understanding Fibrocartilaginous Embolism Fibrocartilaginous embolism is a condition marked by the sudden obstruction of blood vessels due to small fragments
When the Disc Strikes: Rethinking Fibrocartilaginous Embolism Read Post »
Autoimmune nodopathies: a clinical review
Understanding Autoimmune Nodopathies Autoimmune nodopathies represent a diverse group of disorders wherein the body’s immune system mistakenly targets and attacks
Autoimmune nodopathies: a clinical review Read Post »
The emerging role of B cells in immune-mediated demyelinating diseases: mechanisms and therapeutic implications
Emerging Role of B Cells in Demyelination The contribution of B cells to the pathophysiology of immune-mediated demyelinating diseases, such
Effectiveness and Safety of Plasmapheresis in MOGAD Attacks: A Systematic Review and Meta-Analysis
Plasmapheresis Mechanism in MOGAD Plasmapheresis, also known as therapeutic plasma exchange, involves the removal and replacement of a patient’s plasma,
Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis
Study Overview This study aimed to investigate the relationship between anti-CD20 B cell depletion therapies and the presence of circulating
Molecular Tumor Board: H3K27M Diffuse Midline Glioma Diagnosed During Pregnancy by Cerebrospinal Fluid Next-Generation Sequencing
Study Overview This study centers on a unique case of diffuse midline glioma, characterized by the H3K27M mutation, identified during
Tumefactive demyelinating disorders as neoplasm mimics: description of a typical case and literature review
Study Overview This study investigates the phenomenon of tumefactive demyelinating disorders, which can often masquerade as neoplasms on imaging studies.
Ocrelizumab-induced colitis acutely managed with ciclosporin
Background and Rationale Ocrelizumab is a monoclonal antibody approved for the treatment of primary progressive multiple sclerosis (PPMS) and relapsing
Ocrelizumab-induced colitis acutely managed with ciclosporin Read Post »
Effectiveness and Safety of Plasmapheresis in MOGAD Attacks: A Systematic Review and Meta-Analysis
Study Overview The systematic review and meta-analysis focused on the therapeutic role of plasmapheresis in patients experiencing attacks linked to